| Revenue growth | 38.1% YoY |
|---|---|
| Margins | EBITDA margin at 24.2%; improved occupancy to 65.0%. |
| Demand visibility | Sustained patient demand; IP/OP volumes up 38.8% and 26.0%. |
| Management confidence | High; citing strength of Pan-India network and IPO flexibility. |
Growth
Revenue grew 38.1% YoY to ₹3,091 Cr; EBITDA increased 26.4% YoY to ₹749 Cr. PAT reached ₹243 Cr.
Outlook
Focusing on clinical integration of Sahyadri, expanding access, and investing in advanced technology like LINAC and surgical robots.
Risks
Integration complexities of Sahyadri acquisition and high debt levels (₹8,435 Cr net debt post-acquisition) are primary concerns.
Investor Presentation filed with NSE, NSE: MANIPALHOS. Summary written with AI assistance from the document.
Manipal Health Enterprises Ltd: key numbers
- Share price
- ₹727.50
- Market cap
- ₹95,694 Cr
- Revenue (annual)
- ₹10,336 Cr
- Net profit (annual)
- ₹892.3 Cr
- Promoter holding
- 72.08%
- FII holding
- 3.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Manipal Health Enterprises Ltd
All →Manipal Health Enterprises Share Pledge
Manipal Health Enterprises disclosed a Reg 31(1) encumbrance over 17.43% of promoter shares. The pledge secures up to Rs 500 Crore of Claypond NCDs.
- Value
- ₹500.0 Cr
Manipal Health Enterprises Debt & Borrowing: ₹5,310 Cr
Manipal Health Enterprises Ltd has utilized IPO proceeds for the full redemption of its subsidiary's outstanding listed non-convertible debentures. The total nominal value redeemed is Rs. 5,310 Crore.
- Value
- ₹5,310 Cr
Manipal Health Enterprises Annual General Meeting
Manipal Health Enterprises issued a notice for its 16th Annual General Meeting scheduled for September 29, 2026, to transact ordinary and special business.
Manipal Health Enterprises Share Pledge
Promoters of Manipal Health Enterprises Limited created an encumbrance on 23,21,47,755 shares, representing 17.43% stake. This pertains to covenants under financing documents for NCDs worth Rs.500 Crore.
- Value
- ₹500.0 Cr
Manipal Health Enterprises Investor Presentation: Key Takeaways
Manipal Health delivered robust Q1 FY27 results, with revenue growing 38% YoY to INR 3,091 Cr and EBITDA up 26% to INR 749 Cr, driven primarily by volume-led inpatient and outpatient growth.
Manipal Health Enterprises Q1 FY27 Results: Net Profit ₹243.4 Cr, Down 4.2% YoY
Manipal Health Enterprises Ltd reported revenue from operations of ₹3,091 Cr (+38.1% YoY) and net profit of ₹243.4 Cr (-4.2% YoY) for Q1 FY27.
- Key figure
- Net profit ₹243.4 Cr · -4.2% YoY